ZHEJIANG RUILIAN PHARMACEUTICAL CO.,LTD.
STRONG R&D ABILITY
HIGH QUALITY&AFFORDABLE
WE REALLY CARE ABOUT YOUR HEALTH
HIGH QUALITY&AFFORDABLE
WE NEVER STOP FOR OUR MISSION
HIGH QUALITY&AFFORDABLE
Product
No. |
PRODUCTS |
CAS No. |
INDICATIONS |
Remark |
1 |
Upadacitinib (Novel Polymorph) |
1310726-60-3 |
Immune system |
DMF* |
2 |
Baricitinib |
1187594-09-7 |
Immune system |
DMF* |
3 |
Tofacitinib Citrate |
540737-29-9 |
Rheumatoid arthritis |
DMF |
4 |
Deucravacitinib (BMS-986165) |
1609392-27-9 |
Lupus-like disease/TYK2 |
TDP |
5 |
Apremilast |
608141-41-9 |
Psoriasis |
DMF |
ZHEJIANG RUILIAN PHARMACEUTICAL CO.,LTD.
ROOM 402,NO.63 HUANCHENG NORTH ROAD, HANGZHOU,CHINA.
Post Code:310003
ZHEJIANG RUILIAN PHARMACEUTICAL CO.,LTD. 浙ICP备2022019310号-1
CONTACT US
Tel:+86-571-87802256
Email: bd@ruilianpharma.com